AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABSI
  4. [SCHEDULE 13G/A] Absci Corporation SEC Filing

[SCHEDULE 13G/A] Absci Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock ABSI logo
Absci Corp

NASDAQ:ABSI

ABSI Rankings

#3503 Ranked by Market Cap
N/A Ranked by Dividends

ABSI Latest News

Aug 25, 2025
Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg
Aug 20, 2025
Absci to Participate in Upcoming Investor Conferences
Aug 12, 2025
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results
Aug 7, 2025
Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target
Jul 30, 2025
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

ABSI Latest SEC Filings

Aug 12, 2025
[8-K/A] Absci Corporation Amends Material Event Report
Aug 12, 2025
[S-3] Absci Corporation Shelf Registration Statement
Aug 12, 2025
[10-Q] Absci Corporation Quarterly Earnings Report
Aug 12, 2025
[8-K] Absci Corporation Reports Material Event
Jul 29, 2025
[SCHEDULE 13G] Absci Corporation SEC Filing

ABSI Stock Data

393.24M
135.46M
9.25%
59.86%
21.08%
Biotechnology
Services-commercial Physical & Biological Research
United States
VANCOUVER